These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24266819)

  • 21. A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.
    Farran B; Dyson G; Craig D; Dombkowski A; Beebe-Dimmer JL; Powell IJ; Podgorski I; Heilbrun L; Bolton S; Bock CH
    Carcinogenesis; 2018 Apr; 39(4):556-561. PubMed ID: 29471417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining PHI and miRNAs as Biomarkers in Prostate Cancer Diagnosis and Prognosis.
    Ibrahim NH; Abdellateif MS; Thabet G; Kassem SH; El-Salam MA; El-Leithy AA; Selim MM
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving the Specificity of PSA Screening with Serum and Urine Markers.
    Kearns JT; Lin DW
    Curr Urol Rep; 2018 Aug; 19(10):80. PubMed ID: 30105509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
    Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Chu C; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Chan JM; Friedlander T; Wyatt AW; Aggarwal R; Paris PL; Carroll PR; Feng F; Witte JS
    Sci Rep; 2021 Mar; 11(1):5040. PubMed ID: 33658587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Early detection of prostate cancer: is serum PSA testing alone sufficient?].
    Börgermann C; Vom Dorp F; Breuer G; Kliner S; Rübben H
    Urologe A; 2010 Nov; 49(11):1351-5. PubMed ID: 20959954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X; Foj L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
    Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.
    Morgan T; Palapattu G; Wei J
    Curr Urol Rep; 2015 Sep; 16(9):63. PubMed ID: 26169584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers.
    Ponti G; Maccaferri M; Manfredini M; Cotugno M; Pellacani G; Conti A; Micali S; Mandrioli M; Tomasi A
    Med Hypotheses; 2018 May; 114():69. PubMed ID: 29602469
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy.
    Yates DR; Rouprêt M; Drouin SJ; Comperat E; Ricci S; Lacave R; Sèbe P; Cancel-Tassin G; Bitker MO; Cussenot O
    Prostate; 2012 Sep; 72(12):1382-8. PubMed ID: 22228175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current results on PSA-based prostate cancer detection].
    Graefen M; Schlomm T; Steuber T; Sauter G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating nucleic acids as biomarkers in breast cancer.
    Schwarzenbach H
    Breast Cancer Res; 2013; 15(5):211. PubMed ID: 24090167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
    Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
    Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel biomarkers and genomic tests in prostate cancer: a critical analysis.
    Falzarano SM; Ferro M; Bollito E; Klein EA; Carrieri G; Magi-Galluzzi C
    Minerva Urol Nefrol; 2015 Sep; 67(3):211-31. PubMed ID: 26054411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
    Duffy MJ
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):310-6. PubMed ID: 21525152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens].
    Iinuma M; Sato K; Ogawa O; Sasaki R; Kato T
    Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):548-56. PubMed ID: 10386054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
    IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer.
    Hori S; Blanchet JS; McLoughlin J
    BJU Int; 2013 Oct; 112(6):717-28. PubMed ID: 22759214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.